APEXIGEN INC (APGN) Stock Analyst Earnings Estimates
NASDAQ:APGN - Nasdaq - US03759B1026 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 56.52% | N/A 11.11% | N/A 623.19% | N/A 62.82% | N/A 46.09% | N/A 82.56% | N/A -21.19% | |
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | N/A | N/A 50.65% | N/A -10.18% | N/A -54.08% | N/A -29.86% | N/A -41.23% | N/A -29.73% | N/A 27.44% | N/A 308.04% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A 70.12% | N/A 47.00% | N/A 1.89% | N/A -65.38% | N/A -3.49% | N/A -14.61% | N/A 31.37% | N/A |
All data in USD
| Q3 / 23 | Q4 / 23 | |
|---|---|---|
| EPS Q2Q % growth | -0.19 52.73% | -0.08 75.27% |
| Revenue Q2Q % growth | 1.53M | 1.53M |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -4.794M 43.37% | -4.896M 42.80% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | -0.24 | -0.19 | -0.05 | -23.84% |
| Q1 2023 Q2Q % growth | -0.25 | -0.19 | -0.06 | -29.00% |
| Q4 2022 Q2Q % growth | -0.33 | -0.36 | 0.03 | 9.29% |
| Q3 2022 Q2Q % growth | -0.41 | -0.29 | -0.12 | -43.56% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |